The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

SOHO 2019 | Which classes of drugs are used for non-antibody based immunotherapies in MM?

During SOHO 2019, Houston, US, the Multiple Myeloma Hub were pleased to talk with Dr Nina Shah from University of California, San Francisco, US, about different classes of drugs used as non-antibody based immunotherapies in multiple myeloma.

Dr Shah highlights promising results of CAR T-cells, bispecific T-cell engagers (BiTEs), and antibody-drug conjugates.

Which classes of drugs are used for non-antibody based immunotherapies in MM?

Share: